Roche AG
Palo Alto, CA 94304
Share:
International Census of Marine Microbes Reveals a Greater Level of Marine Diversity Using Ultrafast Sequencing System from Roche Diagnostics
MANHEIM, Germany, Sept. 6 // -- Roche Applied Science, a business area of Roche Diagnostics, and 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (NASDAQ:CRGN), today announced that the International Census of Marine Microbes has purchased a Genome Sequencer 20(TM) system as part of a multi-institutional study of microbial life in the world's oceans. The...
Read More »Roche Makes Offer to Acquire Ventana for $75.00 Per Share in Cash
Roche to Expand Into Fast Growing Tissue-Based Cancer Diagnostics, Enhancing Its Position as a Leading Fully-Integrated Personalized Healthcare Company BASEL, Switzerland, June 25 -- Roche (SWX: ROG.VX; RO.S), a world-leading healthcare provider of pharmaceuticals and diagnostics, will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems Inc....
Read More »International Census of Marine Microbes Reveals a Greater Level of Marine Diversity Using Ultrafast Sequencing System from Roche Diagnostics
MANHEIM, Germany, Sept. 6 // -- Roche Applied Science, a business area of Roche Diagnostics, and 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (NASDAQ:CRGN), today announced that the International Census of Marine Microbes has purchased a Genome Sequencer 20(TM) system as part of a multi-institutional study of microbial life in the world's oceans. The...
Read More »